RE:AEZS's Diagnostic Test:Hopefully there will NR on this for the merger approval'
As the partner will probably be a smaller company like Pharmanovie in Europe I don't expect they can afford the trials remboursement
novi seems to indicate sales levels to be low end of range so 50 M is probably not acieceable
3 to 5 more likely
in addition a small marketing company would take a number of years to get to this level
test mechanisms exist already so the challenge will be switching - this is not easy